Abstract
The tremendous need for bone tissue in numerous clinical situations and the limited availability of suitable bone grafts are driving the development of tissue engineering approaches to bone repair. In order to engineer viable bone grafts, one needs to understand the mechanisms of native bone development and fracture healing, as these processes should ideally guide the selection of optimal conditions for tissue culture and implantation. Engineered bone grafts have been shown to have capacity for osteogenesis, osteoconduction, osteoinduction and osteointegration - functional connection between the host bone and the graft. Cells from various anatomical sources in conjunction with scaffolds and osteogenic factors have been shown to form bone tissue in vitro. The use of bioreactor systems to culture cells on scaffolds before implantation further improved the quality of the resulting bone grafts. Animal studies confirmed the capability of engineered grafts to form bone and integrate with the host tissues. However, the vascularization of bone remains one of the hurdles that need to be overcome if clinically sized, fully viable bone grafts are to be engineered and implanted. We discuss here the biological guidelines for tissue engineering of bone, the bioreactor cultivation of human mesenchymal stem cells on three-dimensional scaffolds, and the need for vascularization and functional integration of bone grafts following implantation.
Keywords: Bone grafts, tissue engineering, mesenchymal cells, bone development, vascularization, bioreactor
Current Stem Cell Research & Therapy
Title: Tissue Engineered Bone Grafts: Biological Requirements, Tissue Culture and Clinical Relevance
Volume: 3 Issue: 4
Author(s): Mirjam Frohlich, Warren L. Grayson, Leo Q. Wan, Darja Marolt, Matej Drobnic and Gordana Vunjak- Novakovic
Affiliation:
Keywords: Bone grafts, tissue engineering, mesenchymal cells, bone development, vascularization, bioreactor
Abstract: The tremendous need for bone tissue in numerous clinical situations and the limited availability of suitable bone grafts are driving the development of tissue engineering approaches to bone repair. In order to engineer viable bone grafts, one needs to understand the mechanisms of native bone development and fracture healing, as these processes should ideally guide the selection of optimal conditions for tissue culture and implantation. Engineered bone grafts have been shown to have capacity for osteogenesis, osteoconduction, osteoinduction and osteointegration - functional connection between the host bone and the graft. Cells from various anatomical sources in conjunction with scaffolds and osteogenic factors have been shown to form bone tissue in vitro. The use of bioreactor systems to culture cells on scaffolds before implantation further improved the quality of the resulting bone grafts. Animal studies confirmed the capability of engineered grafts to form bone and integrate with the host tissues. However, the vascularization of bone remains one of the hurdles that need to be overcome if clinically sized, fully viable bone grafts are to be engineered and implanted. We discuss here the biological guidelines for tissue engineering of bone, the bioreactor cultivation of human mesenchymal stem cells on three-dimensional scaffolds, and the need for vascularization and functional integration of bone grafts following implantation.
Export Options
About this article
Cite this article as:
Frohlich Mirjam, Grayson L. Warren, Wan Q. Leo, Marolt Darja, Drobnic Matej and Vunjak- Novakovic Gordana, Tissue Engineered Bone Grafts: Biological Requirements, Tissue Culture and Clinical Relevance, Current Stem Cell Research & Therapy 2008; 3 (4) . https://dx.doi.org/10.2174/157488808786733962
| DOI https://dx.doi.org/10.2174/157488808786733962 |
Print ISSN 1574-888X |
| Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
Call for Papers in Thematic Issues
Molecular Mechanisms and Translational Strategies Targeting the Disease Immune Microenvironment
This thematic issue aims to highlight recent advances in deciphering the molecular mechanisms underlying the disease immune microenvironment, with a particular focus on cancer and chronic inflammatory conditions. It will bring together cutting-edge research in immune regulation, biomarker discovery, epigenetic remodeling, and post-translational modifications that influence disease progression and therapeutic ...read more
Stem Cells and Their Derivatives in Cardiovascular Diseases and Complications
Cardiovascular diseases (CVDs) are a global health burden. Stem cells and their derivatives, such as extracellular vesicles (EVs), offer therapeutic opportunities for CVDs and their complications. This thematic issue of Current Stem Cell Research & Therapy will showcase the latest research on the mechanisms by which stem cells and EVs ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protective Effects of Anesthetics on Vascular Function Related to K<sup>+</sup> Channels
Current Pharmaceutical Design Recent Updates on Current and Upcoming Biomarkers for Cardiovascular Diseases
Current Pharmaceutical Design Synthesis and Evaluation of Morpholinoethyl Ester Conjugate of N-acetylcysteine in Ovalbumin-induced Airway Hyperresponsiveness in Sprague Dawley Rats
Letters in Drug Design & Discovery The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE
Current Pharmaceutical Design Computer-Aided Drug Design for AMP-Activated Protein Kinase Activators
Current Computer-Aided Drug Design Patent Selections
Recent Patents on Engineering Brutons Tyrosine Kinase as a New Therapeutic Target
Anti-Cancer Agents in Medicinal Chemistry Potential Role of Acrolein in Neurodegeneration and in Alzheimers Disease
Current Molecular Pharmacology Anionic Host Defence Peptides from the Plant Kingdom: Their Anticancer Activity and Mechanisms of Action
Protein & Peptide Letters Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives
Current Topics in Medicinal Chemistry Extranuclear Effects of Thyroid Hormones in Skeletal Muscle
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Myelodysplastic/Myeloproliferative Neoplasms
Current Cancer Therapy Reviews Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design Cannabis: A Treasure Trove or Pandora's Box?
Mini-Reviews in Medicinal Chemistry The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents
CNS & Neurological Disorders - Drug Targets Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
Current Medicinal Chemistry Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery The Relevance of Supplemental Vitamin D in Malignancies
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Strategies of Plant-derived Compounds for Diabetes Via Regulation of Monocyte Chemoattractant Protein-1
Current Medicinal Chemistry Nanoparticulate Iron Oxide Contrast Agents for Untargeted and Targeted Cardiovascular Magnetic Resonance Imaging
Current Nanoscience





